glp 1 agonists approved for weight loss Indications GLP-1/GIP RA Summary Sheet and Beyond! The New Weight Management Meds

However, since these receptors mediate the diverse biologic actions of more than a dozen ligands 23,24,25 , there are potential concerns with broad ActRIIA/B blockade as an approach to maintain or increase muscle growth

doi: 10.3390/nu16010063

In addition, comorbid conditions such as hypertension and obesity further elevate risk

10.1016/S2666-7568(23)00211-8 Lancet Healthy Longev

2021;4(3) doi: 10.1001/jamanetworkopen.2021.1009

119 demonstrated that exenatide combined with metformin ( n = 19 patients) led to more pronounced reductions in body weight (mean reduction of 4.5 kg) and WC (by 4 cm) compared to metformin alone ( n = 21 patients)